onpointadvisor (< 20)

Hisamitsu Buys Noven; Salonpas Strengthens Topical Analgesic Presence [JNJ,CHTT,KG]

August 30, 2009 – Comments (0) | RELATED TICKERS: JNJ , CHTT , KG

On August 27th Hisamitsu (Japan) announced the closing of its $428MM all-cash deal to acquire Noven Pharmaceuticals of Miami, FL.  Noven will remain a wholly owned, independent subsidiary of Hisamitsu.  This continues Hisamitsu's quiet but steady consolidation of its Salonpas topical analgesic business in the US at a time when conventional players like Ben Gay (JNJ), Wellpatch (Mentholatum), and Icy Hot (CHTT) remain vulnerable to legal, technology, and regulatory challenge in the parity market defined by the FDA monographs...   read more at: